地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:13212737804
传真:13212737804
邮箱:sales@amyjet.com

艾美捷科技代理BioGenex品牌产品。
Biogenex位于美国旧金山,是抗原修复的发明者,是致力于研发生产准确、可靠、可重复性的高效检测方法的自动化和标准化的先驱。BioGenex拥有全面的免疫组化全自动处理系统,包括i1000抗原修复系统、i6000自动染色仪、iVISION数码成像分析系统等,具有检测诊断的高度一致性,为科研和临床诊治提供高质量的参考依据。Biogenx i 系列免疫组化全自动处理系统是使您的科研和临床病理诊断国际化的最佳途径。
BioGenex is a global market leader and an innovator in providing customer-centric molecular pathology solutions and complete walk-away automation of cell and tissue staining. We develop, manufacture and market automated slide-based staining instruments and offer a broad range of histology products for immunohistochemistry (IHC), in-situ hybridization (ISH), miRNA, in situ PCR.
BioGenex的主要产品包括:
(1)IHC
Automation
Primary Antibodies
Antigen Retrieval & Dewax
Detection Systems
Controls
Ancillaries
(2)ISH/CISH
Automation
ISH/CISH Probes
Nucleic Retrieval & Dewax
Detection Systems
Ancillaries
(3)FISH
eFISH Automation
eFISH Probes
Nucleic Retrieval & Dewax
eFISH Visualization Kits
eFISH Ancillaries
(4)miRNA
miRNA Automation
miRNA Probes & Controls
Nucleic Retrieval & Dewax
Detection Systems
Ancillaries
(5)Multiplexing & Double Staining
Automation
Antibody Cocktails
Multiplexing
Antigen Retrieval & Dewax
Detection Systems
Ancillaries
(6)Special Stains
Automation
Special Stains
Ancillaries
(7)In Situ PCR
(8)1IF
" data-original="http://aves.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理BioGenex品牌产品"> 艾美捷科技代理BioGenex品牌产品
invivoCrown IV0119替换BioXCell BE0004-1
invivoCrown IV0111替换BioXCell BE0036
invivoCrown IV0113替换BioXCell BE0075

艾美捷科技代理Schircks Laboratories品牌。
瑞士Schircks Laboratories由B.Schircks博士于1980年创立,主要生产蝶啶及蝶啶类化合物(Pteridines)。至今,Schircks实验室合成了100多种蝶啶类化合物,主要用于科学研究和临床诊断应用。产品包括:
<| 11.180 | 6-(L-1,2,3-Trihydroxybutyl)-pterin [Rhamnopterin] |
| 11.182 | (6R,S)-5,6,7,8-Tetrahydro-L-rhamnopterin dihydrochloride |
| 11.203 | L-Biopterin [L-erythro-Biopterin] |
| 11.206 | 7,8-Dihydro-L-biopterin |
| 11.209 | (6R,S)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride |
| 11.212 | (6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride |
| 11.213 | (6R)-5,6,7,8-Tetrahydro-L-biopterin dihydrochloride |
| 11.215 | (6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate |
| 11.216 | (6S)-5,6,7,8-Tetrahydro-L-biopterin sulfate |
| 11.217 | (6R)-5-Methyl-5,6,7,8-tetrahydro-L-biopterin dihydrochloride |
| 11.218 | D-Biopterin [D-erythro-Biopterin] |
| 11.220 | (6R,S)-5,6,7,8-Tetrahydro-D-biopterin dihydrochloride |
| 11.221 | D-threo-Biopterin [Dictyopterin] |
| 11.223 | (6R,S)-5,6,7,8-Tetrahydro-D-threo-biopterin dihydrochloride |
| 11.228 | Deoxysepiapterin |
| 11.229 | 6-((1R,S)-Hydroxypropyl)pterin [(1'R,S)-2'-Deoxybiopterin] |
| 11.231 | 7-Biopterin |
| 11.234 | 7-Tetrahydro-L-biopterin dihydrochloride |
| 11.260 | Oncopterin |
| 11.270 | 4-Hydroxy-6-(L-erythro-1,2-dihydroxy-propyl)-2-(methylthio)pteridine |
| 11.280 | 4-Amino-L-biopterin [2,4-Diamino-6-(L-erythro-1',2'-dihydroxypropyl)pteridine] |
| 11.282 | 4-Amino-(6R,S)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride |
| 11.283 | 4-Amino-(6R)-5,6,7,8-tetrahydro-L-biopterin dihydrochloride |
| 11.303 | D-Neopterin [D-erythro-Neopterin] |
| 11.306 | 7,8-Dihydro-D-neopterin |
| 11.307 | 7,8-Dihydro-D-neopterin-3’-triphosphate (Please refer to our reference 8) |
| 11.309 | (6R,S)-5,6,7,8-Tetrahydro-D-neopterin dihydrochloride |
| 11.314 | D-Neopterin-3’-monophosphate, lithium salt |
| 11.315 | 7,8-Dihydro-D-neopterin-3’-monophosphate, lithium salt |
| 11.320 | 3'-Hydroxy-D-sepiapterin |
| 11.330 | 7-Neopterin |
| 11.340 | L-Monapterin [L-threo-Neopterin] |
| 11.345 | 7,8-Dihydro-L-monapterin |
| 11.346 | (6R,S)-5,6,7,8-Tetrahydro-L-monapterin dihydrochloride |
| 11.349 | D-Monapterin [D-threo-Neopterin] |
| 11.403 | Pterin-6-carboxylic acid |
| 11.409 | Pterin-7-carboxylic acid |
| 11.415 | 6-Formylpterin [Pterin-6-aldehyde] |
| 11.416 | 6-Formyl-7,8-dihydropterin |
| 11.418 | Acetyl-6-formylpterin |
| 11.420 | 6-Hydroxymethylpterin |
| 11.421 | 6-Hydroxymethyl-7,8-dihydropterin hydrochloride |
| 11.422 | 6-Hydroxymethyl-7,8-dihydropterin-diphosphate (Please refer to our reference 8) |
| 11.423 | (6R,S)-6-Hydroxymethyl-5,6,7,8-tetrahydropterin dihydrochloride |
| 11.429 | 6-Hydroxymethylpterin-monophosphate |
| 11.438 | 6-Hydroxymethylpterin-diphosphate, lithium salt |
| 11.480 | 6-Methylpterin |
| 11.481 | 6-Methyl-7,8-dihydropterin hydrochloride |
| 11.483 | (6R,S)-6-Methyl-5,6,7,8-tetrahydropterin dihydrochloride |
| 11.503 | 6,7-Dimethylpterin |
| 11.506 | 6,7-Dimethyl-7,8-dihydropterin monohydrochloride |
| 11.509 | 6,7-Dimethyl-5,6,7,8-tetrahydropterin monohydrochloride |
| 11.703 | Leucopterin |
| 11.713 | Xanthopterin |
| 11.716 | Dihydroxanthopterin |
| 11.723 | Isoxanthopterin |
| 11.903 | Pterin |
| 11.906 | 7,8-Dihydropterin (Please refer to our reference 20) |
| 11.909 | 5,6,7,8-Tetrahydropterin dihydrochloride |
| 13.103 | Lumazine |
| 13.203 | 6-Hydroxylumazine |
| 13.206 | 6-Hydroxy-7,8-dihydrolumazine |
| 13.220 | 7-Hydroxylumazine |
| 16.113 | Pteroic acid |
| 16.123 | N10-(Trifluoroacetyl)pteroic acid |
| 16.140 | 10-Formylpteroic acid |
| 16.203 | Folic acid |
| 16.206 | 7,8-Dihydrofolic acid |
| 16.208 | (6S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride |
| 16.209 | (6R,S)-5,6,7,8-Tetrahydrofolic acid trihydrochloride |
| 16.211 | 10-Methylfolic acid |
| 16.215 | 10-Formylfolic acid |
| 16.217 | 10-Formyl-5,6,7,8-tetrahydrofolic acid (Please refer to our reference 19) |
| 16.220 | (6R,S)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt |
| 16.222 | (6R)-5-Formyl-5,6,7,8-tetrahydrofolic acid, calcium salt (unnatural calcium folinate) |
| 16.230 | (6R,S)-5,10-Methenyl-5,6,7,8-tetrahydrofolic acid chloride |
| 16.233 | (6R,S)-5-Methyl-5,6-dihydrofolic acid, ammonium salt |
| 16.235 | (6R,S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt |
| 16.236 | (6S)-5-Methyl-5,6,7,8-tetrahydrofolic acid, calcium salt |
| 16.243 | (6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid trihydrochloride |
| 16.244 | (6R,S)-5-Methyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid trihydrochloride |
| 16.252 | Pteroyldi-γ-L-glutamic acid |
| 16.253 | Pteroyltri-γ-L-glutamic acid has been discontinued |
| 16.254 | Pteroyltetra-γ-L-glutamic acid |
| 16.255 | Pteroylpenta-γ-L-glutamic acid has been discontinued |
| 16.266 | Pteroylhexa-γ-L-glutamic acid, ammonium salt |
| 16.267 | Pteroylhepta-γ-L-glutamic acid, ammonium salt |
| 16.280 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroic acid |
| 16.282 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyldi-γ-L-glutamic acid, lithium salt has been discontinued |
| 16.283 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltri-γ-L-glutamic acid, lithium salt has been discontinued |
| 16.284 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroyltetra-γ-L-glutamic acid, lithium salt |
| 16.285 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylpenta-γ-L-glutamic acid, lithium salt |
| 16.286 | (6R,S)-5-Formyl-5,6,7,8-tetrahydropteroylhexa-γ-L-glutamic acid, lithium salt |
| 16.330 | Aminopterin [4-Aminofolic acid] |
| 16.403 | 4-Amino-10-methylpteroic acid (APA, DAMPA) |
| 16.411 | Methotrexate [4-Amino-10-methylpteroyl-γ-L-glutamic acid] |
| 16.412 | 4-Amino-10-methylpteroyldi-γ-L-glutamic acid, ammonium salt [Methotrexate diglutamate] |
| 16.413 | 4-Amino-10-methylpteroyltri-γ-L-glutamic acid, ammonium salt [Methotrexate triglutamate] |
| 16.414 | 4-Amino-10-methylpteroyltetra-γ-L-glutamic acid, ammonium salt [Methotrexate tetraglutamate] |
| 16.415 | 4-Amino-10-methylpteroylpenta-γ-L-glutamic acid, ammonium salt [Methotrexate pentaglutamate] |
| 16.416 | 4-Amino-10-methylpteroylhexa-γ-L-glutamic acid, ammonium salt [Methotrexate hexaglutamate] |
| 16.417 | 4-Amino-10-methylpteroylhepta-γ-L-glutamic acid, ammonium salt [Methotrexate heptaglutamate] |
| 16.500 | 7-Hydroxymethotrexate |
| 16.701 | p-Aminobenzoyl-L-glutamic acid |
| 16.702 | p-Aminobenzoyldi-γ-L-glutamic acid, ammonium salt |
| 16.703 | p-Aminobenzoyltri-γ-L-glutamic acid, ammonium salt |
| 16.704 | p-Aminobenzoyltetra-γ-L-glutamic acid, ammonium salt |
| 16.705 | p-Aminobenzoylpenta-γ-L-glutamic acid, ammonium salt |
| 16.706 | p-Aminobenzoylhexa-γ-L-glutamic acid, ammonium salt |
| 16.707 | p-Aminobenzoylhepta-γ-L-glutamic acid, ammonium salt has been discontinued |
| 16.901 | Z-Glu-OtBu |
| 16.902 | Z-Glu2-OtBu3 |
| 16.903 | Z-Glu3-OtBu4 |
| 16.904 | Z-Glu4-OtBu5 |
| 16.905 | Z-Glu5-OtBu6 |
| 16.906 | Z-Glu6-OtBu7 |
| 91.303 | D-(5-15N)-Neopterin |
| 96.203 | (5-15N)-Folic acid |
invivoCrown IV0118替换BioXCell BE0055
invivoCrown IV0105替换BioXCell BE0089
invivoCrown IV0100替换BioXCell BE0146
<艾美捷科技代理Protide Pharmaceuticals品牌全系列产品
Protide Pharmaceuticals, Inc.是一家专注于生物制药生产上游工艺的创新型公司。Protide Pharmaceuticals公司的核心产品为血清替代物,其核心价值在于提供高性能、化学成分明确、无动物来源的血清替代物和定制化培养基解决方案,帮助客户大幅减少生物制品生产过程中对胎牛血清或其他动物血清的依赖。,从而提高生物制品生产的效率、一致性、安全性和合规性。
除了血清替代物,Protide Pharmaceuticals公司也提供完整的、优化的无血清培养基配方,专门设计用于支持各种哺乳动物细胞系(如CHO, HEK293, Vero, MRC-5等)在生物反应器中进行高密度培养和高产率生产目标生物分子(如抗体、病毒载体、重组蛋白)。其产品应用于再生医学、肿瘤生物学、细胞生物能量学、肿瘤免疫学、转化医学、表观遗传学,胰岛细胞移植等领域。

▎Protide Pharmaceuticals产品线
● 血清替代品/生物制品生产培养基
Protide Pharmaceuticals的血清替代品通过提供优质、生物一致且功能性的环境,显著改善细胞的生理状态。所有血清替代品均配制成 50 倍浓缩液,这大大降低了成本,并改善了储存和供应链活动。Protide血清替代品不含:酚红、生长因子、类固醇激素、糖皮质激素、细胞粘附分子、生长因子、类固醇激素等物质,可以在其缺失或存在的情况下进行有效研究。细胞分泌的蛋白质可以在不受污染性血清成分干扰的情况下实现高度纯化。
| 品名 | 货号-规格 | 产品描述 |
| TCH™ | 3001-40ml;3002-100ml;3005-100ml | 本血清替代品主要用于人类细胞培养及细胞分泌蛋白的生产。TCH™ 在培养其他哺乳动物细胞时同样有效,且不含动物蛋白。其成分仅包含经热处理的人源蛋白(即人血清白蛋白、人转铁蛋白、重组人胰岛素)。 |
| VaxMax™ | 6004-100ml;6005-500ml;6006-1L | 100倍浓缩液是一种高性价比产品,可显著降低总体血清需求量。在MDBK、MDCK、Vero、CRFK及猪睾丸细胞培养中,使用VaxMax™已展现出显著的产量提升。兽用疫苗生产商已采用VaxMax™来增强生产,同时降低总体成本。VaxMax™通常与0.5%至1% 的血清配合使用。 |
| HemaPro™ | 3300-40ml;3303-100ml | 本产品为无血清添加剂,专为人祖细胞培养而设计。可有效用于癌症干细胞、诱导多能干细胞和间充质干细胞 的研究。不含:促红细胞生成素;重组生长因子。 |
| TM-235™ | 2001-40ml;2002-100ml;2005-500ml | 本血清替代品具有与TCM™类似的特性,但额外添加了适用于需要更高血清浓度(通常超过10%)的细胞类型的成分。TM-235™是一种成分明确且多用途的替代品。 |
| TCM™ | 1001-40ml;1002-100ml;1005-500ml | 本产品是一种通用型血清替代品,适用于多种物种来源的广泛细胞类型。TCM™是一种成分明确且多用途的血清替代品,可有效用于研究生长因子的影响以及蛋白质的生产。 |
● 低温保护剂
| 品名 | 货号-规格 | 产品描述 |
| Stemsol™ USP (DMSO) | PP1250-5ml;PP1300-10ml;PP1350-50ml;PP1400-100ml | 本产品为干细胞冻存溶液,适用于来源于脐带血、外周血、骨髓及其他生物组织和细胞的干细胞。 |
| pZerve™ | 5700-60ml;5720-20ml | pZerve™ 是一款独特的冻存溶液,不含 DMSO、胎牛血清或动物蛋白。本品为即用型,无需任何稀释或进一步处理。适用细胞类型包括:肥大细胞、树突细胞、间充质细胞、人转移性前列腺腺癌细胞、人结肠腺癌细胞,人转化胚肾细胞。 |
| Cellvation™ | 5001-60ml | Cellvation™ 是一款独特的冻存溶液,不含 DMSO 或胎牛血清。本品使用便捷,并能提供最佳的细胞复苏效果。在冷冻程序启动前,细胞可置于 Cellvation™ 中较长时间。本品为即用型,适用于无血清培养基或含血清培养基培养的细胞。 |
| MiCord™ 55% DMSO USP 5% Dextran USP | 1505-5ml;1500-7ml;;1700-10ml;1550-50ml;1600-100ml | 本产品为干细胞冻存溶液,适用于来源于脐带血、外周血、骨髓及其他生物组织和细胞的干细胞。 |
| 2-8CELLsius™ + DMSO,5% DMSO | PP338DM5-10ml;PP338DM5-100ml;PP338DM5-100B | 当与DMSO配合使用时,2-8CELLsius™可用作冻存液。2-8CELLsius™ + DMSO冻存液是一种细胞保护性、无蛋白溶液,含有生物稳定剂,可支持冻融后细胞的高存活率。其通过针对超低温下细胞生理学的创新方法,实现最佳的细胞复苏效果。不含:任何生长因子,激素以及抗生素。 |
| 2-8CELLsius™ + DMSO,10% DMSO | PP338DM10-10ml;PP338DM10-100ml;PP338DM10-100B;PP338DM10-1000B | |
| 2-8CELLsius™ + DMSO,20% DMSO | PP338DM20-100B;PP338DM20-1000B |
● 细胞处理
| 品名 | 货号-规格 | 产品描述 |
| 2-8CELLsius™ | PP338-100ml;PP338-500ml;PP338-1000;PP338-1000B | 即用型、平衡、细胞保护性、无蛋白溶液,含生物稳定剂,适用于:短期储存、再生医学、干细胞处理以及生物材料运输。 |
| Dextran 40 in 0.9% NaCl | PP1850-50ml;PP1840-1000ml;PP1880-250ml;PP1900-500ml | - |
| Dulbecco’s Phosphate Buffered Saline (10X) PBS | PBS210-500ml;PBS211-1000ml | 无钙镁储存条件:15-30°C;包装于PETG瓶;稳定性:至少6个月;无菌过滤 |
| Dulbecco’s Phosphate Buffered Saline (1X) PBS | PBS200-500ml;PBS201-1000ml | 无钙镁储存条件:15-30°C;包装于PETG瓶;稳定性:至少6个月;无菌过滤 |
| Hank’s Balanced Salt Solution (1X) HBSS | HS240-500ml;HS241-1000ml | 无钙镁配方:储存温度 4-8°C;无酚红配方;稳定性:至少6个月;含0.35克/升 碳酸氢钠;含1000毫克/升 D-葡萄糖;包装于 PETG 瓶,无菌过滤。cGMP 规范生产。 |
● CIT 胰岛细胞溶液
| 品名 | 货号-规格 |
| Cold Storage/Purification Stock Solution | 111098-1L |
| Phase I Solution | 060899-1L |
invivoCrown IV0106替换BioXCell BE0090
地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18771997407
传真:18995651644
邮箱:sales@amyjet.com
0.1414